MONOPTEROS THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://monopterostx.com
A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Phase 1
- Conditions
- Solid Tumor, AdultAdvanced Solid TumorAdvanced CancerMetastatic CancerRefractory Cancer
- Interventions
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Monopteros Therapeutics Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT04859777
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸St. John's Cancer Center, Santa Monica, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath